Systematic-Review-Drug-Efficiency-Dissertation-Sample-Work-Tutors-India
Idiopathic Pulmonary Fibrosis (IPF) as the name suggests is a progressive disorder with no known aetiology. It is characterised by the thickening of the alveoli due to scarring resulting in cough. It is known to primarily occur in older adults over 60 years of age. The findings of IPF have a known association of Usual Interstitial Pneumonia (UIP) (Raghu et al., 2011; Kawano-Dourado & Kairalla, 2013; Wells, 2013). It has been deemed that the prognosis is generally poor when UIP has been confirmed (King et al., 2001b). The median survival rate of IPF is 50%, typically around two years after diagnosis (Raghu et al., 2011; King et al., 2001b).
Idiopathic Pulmonary Fibrosis (IPF) as the name suggests is a progressive disorder with no known aetiology. It is characterised by the thickening of the alveoli due to scarring resulting in cough. It is known to primarily occur in older adults over 60 years of age. The findings of IPF have a known association of Usual Interstitial Pneumonia (UIP) (Raghu et al., 2011; Kawano-Dourado & Kairalla, 2013; Wells, 2013). It has been deemed that the prognosis is generally poor when UIP has been confirmed (King et al., 2001b). The median survival rate of IPF is 50%, typically around two years after diagnosis (Raghu et al., 2011; King et al., 2001b).
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Raghu, G., Brown, K.K., Bradford, W.Z., Starko, K., Noble, P.W., Schwartz, D.A. & King,<br />
T.E. (2004). A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with<br />
Idiopathic Pulmonary Fibrosis. New England Journal of Medicine. [Online]. 350 (2). pp.<br />
125–133. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa030511.<br />
Raghu, G., Brown, K.K., Costabel, U., Cottin, V., du Bois, R.M., Lasky, J.A., Thomeer, M.,<br />
Utz, J.P., Khandker, R.K., McDermott, L. & Fatenejad, S. (2008). Treatment of<br />
idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.<br />
American journal of respiratory and critical care medicine. [Online]. 178 (9). pp. 948–<br />
55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18669816.<br />
Raghu, G., Chen, S.-Y., Yeh, W.-S., Maroni, B., Li, Q., Lee, Y.-C. & Collard, H.R. (2014).<br />
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older:<br />
incidence, prevalence, and survival, 2001–11. The Lancet Respiratory Medicine.<br />
[Online]. 2 (7). pp. 566–572. Available from:<br />
http://linkinghub.elsevier.com/retrieve/pii/S2213260014701018.<br />
Raghu, G., Collard, H.R., Egan, J.J., Martinez, F.J., Behr, J., Brown, K.K., Colby, T. V.,<br />
Cordier, J.-F., Flaherty, K.R., Lasky, J.A., Lynch, D.A., Ryu, J.H., Swigris, J.J., Wells,<br />
A.U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D.M.,<br />
Johkoh, T., Kim, D.S., King, T.E., Kondoh, Y., Myers, J., Müller, N.L., Nicholson, A.G.,<br />
Richeldi, L., Selman, M., Dudden, R.F., Griss, B.S., Protzko, S.L. & Schünemann, H.J.<br />
(2011). An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis:<br />
evidence-based guidelines for diagnosis and management. American Journal of<br />
Respiratory and Critical Care Medicine. 183 (6). pp. 788–824.<br />
Raghu, G., Freudenberger, T.D., Yang, S., Curtis, J.R., Spada, C., Hayes, J., Sillery, J.K.,<br />
Pope, C.E. & Pellegrini, C.A. (2006a). High prevalence of abnormal acid gastrooesophageal<br />
reflux in idiopathic pulmonary fibrosis. The European respiratory journal.<br />
[Online]. 27 (1). pp. 136–42. Available from:<br />
http://www.ncbi.nlm.nih.gov/pubmed/16387946.<br />
Raghu, G., Johnson, W.C., Lockhart, D. & Mageto, Y. (1999a). Treatment of idiopathic<br />
pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective,<br />
© 2017-2018 All Rights Reserved, No part of this document should be modified/used without prior consent<br />
<strong>Tutors</strong> <strong>India</strong> - Your trusted mentor since 2001<br />
www.tutorindia.com I UK # +44-1143520021, info@tutorsindia.com<br />
Page 154 of 172
Change language